Works matching IS 2076393X AND DT 2024 AND VI 12 AND IP 6
Results: 139
Accelerating Global Measles and Rubella Eradication—Saving Millions of Lives, Preventing Disability, and Averting the Next Pandemic.
- Published in:
- Vaccines, 2024, v. 12, n. 6, p. 699, doi. 10.3390/vaccines12060699
- By:
- Publication type:
- Article
Addressing the Dangerous Consequences of the Resurgence of Measles and Rubella: The Critical Need for a Global Target.
- Published in:
- Vaccines, 2024, v. 12, n. 6, p. 698, doi. 10.3390/vaccines12060698
- By:
- Publication type:
- Article
Measles and Rubella Diagnostic and Classification Challenges in Near- and Post-Elimination Countries.
- Published in:
- Vaccines, 2024, v. 12, n. 6, p. 697, doi. 10.3390/vaccines12060697
- By:
- Publication type:
- Article
Progress and Challenges in Measles and Rubella Elimination in the WHO European Region.
- Published in:
- Vaccines, 2024, v. 12, n. 6, p. 696, doi. 10.3390/vaccines12060696
- By:
- Publication type:
- Article
Breakthrough Measles among Vaccinated Adults Born during the Post-Soviet Transition Period in Mongolia.
- Published in:
- Vaccines, 2024, v. 12, n. 6, p. 695, doi. 10.3390/vaccines12060695
- By:
- Publication type:
- Article
A World without Measles and Rubella: Addressing the Challenge of Vaccine Hesitancy.
- Published in:
- Vaccines, 2024, v. 12, n. 6, p. 694, doi. 10.3390/vaccines12060694
- By:
- Publication type:
- Article
Evolution and Contribution of a Global Partnership against Measles and Rubella, 2001–2023.
- Published in:
- Vaccines, 2024, v. 12, n. 6, p. 693, doi. 10.3390/vaccines12060693
- By:
- Publication type:
- Article
The Case for Assessing the Drivers of Measles Vaccine Uptake.
- Published in:
- Vaccines, 2024, v. 12, n. 6, p. 692, doi. 10.3390/vaccines12060692
- By:
- Publication type:
- Article
Determinants of Systemic SARS-CoV-2-Specific Antibody Responses to Infection and to Vaccination: A Secondary Analysis of Randomised Controlled Trial Data.
- Published in:
- Vaccines, 2024, v. 12, n. 6, p. 691, doi. 10.3390/vaccines12060691
- By:
- Publication type:
- Article
Sustaining the Elimination of Measles, Rubella and Congenital Rubella Syndrome in the Americas, 2019–2023: From Challenges to Opportunities.
- Published in:
- Vaccines, 2024, v. 12, n. 6, p. 690, doi. 10.3390/vaccines12060690
- By:
- Publication type:
- Article
Vaccination with a Human Papillomavirus L2 Multimer Provides Broad Protection against 17 Human Papillomavirus Types in the Mouse Cervicovaginal Challenge Model.
- Published in:
- Vaccines, 2024, v. 12, n. 6, p. 689, doi. 10.3390/vaccines12060689
- By:
- Publication type:
- Article
COVID-19 Booster Vaccination Status and Long COVID in the United States: A Nationally Representative Cross-Sectional Study.
- Published in:
- Vaccines, 2024, v. 12, n. 6, p. 688, doi. 10.3390/vaccines12060688
- By:
- Publication type:
- Article
The JMU-SalVac-System: A Novel, Versatile Approach to Oral Live Vaccine Development.
- Published in:
- Vaccines, 2024, v. 12, n. 6, p. 687, doi. 10.3390/vaccines12060687
- By:
- Publication type:
- Article
Immune Responses and Protection Profiles in Mice Induced by Subunit Vaccine Candidates Based on the Extracellular Domain Antigen of Respiratory Syncytial Virus G Protein Combined with Different Adjuvants.
- Published in:
- Vaccines, 2024, v. 12, n. 6, p. 686, doi. 10.3390/vaccines12060686
- By:
- Publication type:
- Article
Field Trials of Live and Inactivated Camelpox Vaccines in Kazakhstan.
- Published in:
- Vaccines, 2024, v. 12, n. 6, p. 685, doi. 10.3390/vaccines12060685
- By:
- Publication type:
- Article
SARS-CoV-2-Specific Immune Cytokine Profiles to mRNA, Viral Vector and Protein-Based Vaccines in Patients with Multiple Sclerosis: Beyond Interferon Gamma.
- Published in:
- Vaccines, 2024, v. 12, n. 6, p. 684, doi. 10.3390/vaccines12060684
- By:
- Publication type:
- Article
Immunogenicity, Safety, and Immune Persistence of One Dose of SARS-CoV-2 Recombinant Adenovirus Type-5 Vectored Vaccine in Children and Adolescents Aged 6–17 Years: An Immunobridging Trial.
- Published in:
- Vaccines, 2024, v. 12, n. 6, p. 683, doi. 10.3390/vaccines12060683
- By:
- Publication type:
- Article
Hybrid Immunity and the Incidence of SARS-CoV-2 Reinfections during the Omicron Era in Frontline Healthcare Workers.
- Published in:
- Vaccines, 2024, v. 12, n. 6, p. 682, doi. 10.3390/vaccines12060682
- By:
- Publication type:
- Article
Water-Soluble and Freezable Aluminum Salt Vaccine Adjuvant.
- Published in:
- Vaccines, 2024, v. 12, n. 6, p. 681, doi. 10.3390/vaccines12060681
- By:
- Publication type:
- Article
Evaluation of Formalin-Inactivated Vaccine Efficacy against Red Seabream Iridovirus (RSIV) in Laboratory and Field Conditions.
- Published in:
- Vaccines, 2024, v. 12, n. 6, p. 680, doi. 10.3390/vaccines12060680
- By:
- Publication type:
- Article
Assessing Predictive Value of SARS-CoV-2 Epitope-Specific CD8 + T-Cell Response in Patients with Severe Symptoms.
- Published in:
- Vaccines, 2024, v. 12, n. 6, p. 679, doi. 10.3390/vaccines12060679
- By:
- Publication type:
- Article
Real-World Assessment of Recommended COVID-19 Vaccination Waiting Period after Chemotherapy.
- Published in:
- Vaccines, 2024, v. 12, n. 6, p. 678, doi. 10.3390/vaccines12060678
- By:
- Publication type:
- Article
Exploring the Potential of Natural Killer Cell-Based Immunotherapy in Targeting High-Grade Serous Ovarian Carcinomas.
- Published in:
- Vaccines, 2024, v. 12, n. 6, p. 677, doi. 10.3390/vaccines12060677
- By:
- Publication type:
- Article
S2 Peptide-Conjugated SARS-CoV-2 Virus-like Particles Provide Broad Protection against SARS-CoV-2 Variants of Concern.
- Published in:
- Vaccines, 2024, v. 12, n. 6, p. 676, doi. 10.3390/vaccines12060676
- By:
- Publication type:
- Article
An Overview of the Strategies to Boost SARS-CoV-2-Specific Immunity in People with Inborn Errors of Immunity.
- Published in:
- Vaccines, 2024, v. 12, n. 6, p. 675, doi. 10.3390/vaccines12060675
- By:
- Publication type:
- Article
Glycoprotein-Specific Polyclonal Antibodies Targeting Machupo Virus Protect Guinea Pigs against Lethal Infection.
- Published in:
- Vaccines, 2024, v. 12, n. 6, p. 674, doi. 10.3390/vaccines12060674
- By:
- Publication type:
- Article
Safety Assessment of Concurrent Vaccination with the HPV Vaccine and the COVID-19 Vaccine in Fujian Province, China: A Retrospective Study.
- Published in:
- Vaccines, 2024, v. 12, n. 6, p. 673, doi. 10.3390/vaccines12060673
- By:
- Publication type:
- Article
Effectiveness and Safety of the COVID-19 Vaccine in Patients with Rheumatoid Arthritis in a Real-World Setting.
- Published in:
- Vaccines, 2024, v. 12, n. 6, p. 672, doi. 10.3390/vaccines12060672
- By:
- Publication type:
- Article
Human Papillomavirus Perceptions, Vaccine Uptake, and Sexual Risk Factors in Students Attending a Large Public Midwestern University.
- Published in:
- Vaccines, 2024, v. 12, n. 6, p. 671, doi. 10.3390/vaccines12060671
- By:
- Publication type:
- Article
mRNA Technology and Mucosal Immunization.
- Published in:
- Vaccines, 2024, v. 12, n. 6, p. 670, doi. 10.3390/vaccines12060670
- By:
- Publication type:
- Article
Prior COVID-19 Diagnosis, Severe Outcomes, and Long COVID among U.S. Adults, 2022.
- Published in:
- Vaccines, 2024, v. 12, n. 6, p. 669, doi. 10.3390/vaccines12060669
- By:
- Publication type:
- Article
Factors Related to Caregivers' Intention to Vaccinate Their Elderly Family Members with Major Neurocognitive Disorders against COVID-19.
- Published in:
- Vaccines, 2024, v. 12, n. 6, p. 668, doi. 10.3390/vaccines12060668
- By:
- Publication type:
- Article
Insect Cell-Based Quadrivalent Seasonal Influenza Virus-like Particles Vaccine Elicits Potent Immune Responses in Mice.
- Published in:
- Vaccines, 2024, v. 12, n. 6, p. 667, doi. 10.3390/vaccines12060667
- By:
- Publication type:
- Article
Lipid Nanoparticles Outperform Electroporation in Delivering Therapeutic HPV DNA Vaccines.
- Published in:
- Vaccines, 2024, v. 12, n. 6, p. 666, doi. 10.3390/vaccines12060666
- By:
- Publication type:
- Article
Association between Reactogenicity and Immunogenicity in a Vaccinated Cohort with Two mRNA SARS-CoV-2 Vaccines at a High-Complexity Reference Hospital: A Post Hoc Analysis on Immunology Aspects of a Prospective Cohort Study.
- Published in:
- Vaccines, 2024, v. 12, n. 6, p. 665, doi. 10.3390/vaccines12060665
- By:
- Publication type:
- Article
Advances in Nucleic Acid Universal Influenza Vaccines.
- Published in:
- Vaccines, 2024, v. 12, n. 6, p. 664, doi. 10.3390/vaccines12060664
- By:
- Publication type:
- Article
SARS-CoV-2 Humoral and Cellular Immune Responses in People Living with HIV.
- Published in:
- Vaccines, 2024, v. 12, n. 6, p. 663, doi. 10.3390/vaccines12060663
- By:
- Publication type:
- Article
COVID-19 Vaccine Acceptance, Hesitancy, and Uptake in People with Diabetes in Australia.
- Published in:
- Vaccines, 2024, v. 12, n. 6, p. 662, doi. 10.3390/vaccines12060662
- By:
- Publication type:
- Article
Identifying Key Drivers of Efficient B Cell Responses: On the Role of T Help, Antigen-Organization, and Toll-like Receptor Stimulation for Generating a Neutralizing Anti-Dengue Virus Response.
- Published in:
- Vaccines, 2024, v. 12, n. 6, p. 661, doi. 10.3390/vaccines12060661
- By:
- Publication type:
- Article
A Narrative Review on the Promising Potential of Graphene in Vaccine Design: Evaluating the Benefits and Drawbacks of Carbon Nanoplates in Nanovaccine Production.
- Published in:
- Vaccines, 2024, v. 12, n. 6, p. 660, doi. 10.3390/vaccines12060660
- By:
- Publication type:
- Article
mRNA Vaccine for Alzheimer's Disease: Pilot Study.
- Published in:
- Vaccines, 2024, v. 12, n. 6, p. 659, doi. 10.3390/vaccines12060659
- By:
- Publication type:
- Article
COVID-19 Vaccination in Pregnancy: Pilot Study of Plasma MicroRNAs Associated with Inflammatory Cytokines after COVID-19 mRNA Vaccination.
- Published in:
- Vaccines, 2024, v. 12, n. 6, p. 658, doi. 10.3390/vaccines12060658
- By:
- Publication type:
- Article
Effectiveness of BNT162b2 Vaccine for Preventing COVID-19-Related Hospitalizations: A Test-Negative Case–Control Study.
- Published in:
- Vaccines, 2024, v. 12, n. 6, p. 657, doi. 10.3390/vaccines12060657
- By:
- Publication type:
- Article
ANCA-Positive Small-Vessel Vasculitis Following SARS-CoV-2 Vaccination—A Systematic Review.
- Published in:
- Vaccines, 2024, v. 12, n. 6, p. 656, doi. 10.3390/vaccines12060656
- By:
- Publication type:
- Article
Glioblastoma Vaccines as Promising Immune-Therapeutics: Challenges and Current Status.
- Published in:
- Vaccines, 2024, v. 12, n. 6, p. 655, doi. 10.3390/vaccines12060655
- By:
- Publication type:
- Article
Understanding COVID-19 Vaccine Acceptance among Healthcare Workers in Indonesia: Lessons from Multi-Site Survey.
- Published in:
- Vaccines, 2024, v. 12, n. 6, p. 654, doi. 10.3390/vaccines12060654
- By:
- Publication type:
- Article
Message Effectiveness of Fear Appeals in Vaccination Communication Campaigns: A Systematic Review.
- Published in:
- Vaccines, 2024, v. 12, n. 6, p. 653, doi. 10.3390/vaccines12060653
- By:
- Publication type:
- Article
Synthetic Peptides Elicit Humoral Response against Porcine Reproductive and Respiratory Syndrome Virus in Swine.
- Published in:
- Vaccines, 2024, v. 12, n. 6, p. 652, doi. 10.3390/vaccines12060652
- By:
- Publication type:
- Article
Effectiveness and Safety of the MVA–BN Vaccine against Mpox in At-Risk Individuals in the United States (USMVAc).
- Published in:
- Vaccines, 2024, v. 12, n. 6, p. 651, doi. 10.3390/vaccines12060651
- By:
- Publication type:
- Article
Multiple Messaging Strategies for Increasing HPV Vaccination Intentions among English- and Spanish-Speaking Parents in the United States and Mexico.
- Published in:
- Vaccines, 2024, v. 12, n. 6, p. 650, doi. 10.3390/vaccines12060650
- By:
- Publication type:
- Article